What is SNWV's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.05B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for SNWV?

P/E (TTM) is 3.43 and 52-week range is $3.92 to $36.42 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s SNWV figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for SNWV?

The company profile lists revenue (TTM) near $44M, net income (TTM) near $14M, EPS (TTM) near $1.58 when available from the market-data feed. Figures are informational and may lag live markets.

Where is SANUWAVE Health Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Eden Prairie, Minnesota, US, 8.6M shares outstanding, ISIN US80303D3052 when available from company profile and filing metadata.

SANUWAVE Health Inc

$SNWV

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$5.62

-3.85%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 55 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

Employees

Website

sanuwave.com/

IPO

2008-11-07

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)